Small blood vessels express specific phenotypical and functional characteristics throughout the body. Alterations in the microcirculation contribute to many correlated physiological and pathological events in related organs. Factors such as comorbidities and genetics contribute to the complexity of this topic. Small vessel disease primarily affects end organs that receive significant cardiac output, such as the brain, kidney, and retina. Despite the differences in location, concurrent changes are seen in the micro-vasculature of the brain, retina, and kidneys under pathological conditions due to their common histological, functional, and embryological characteristics. While the cardiovascular basis of pathology in association with the brain, retina, or kidneys has been well documented, this is a simple review that uniquely considers the relationship between all three organs and highlights the prevalence of coexisting end organ injuries in an attempt to elucidate connections between the brain, retina, and kidneys, which has the potential to transform diagnostic and therapeutic approaches.
27 February 2023 in Journal of Pediatric Surgery Open
Tourette disorder (TD) is a heritable neuropsychiatric and developmental disorder characterized by motor and vocal tics. TD has a complex heterogenous etiology which makesthe identification of genes linked to the disorder challenging.However, previous studies have identified optic atrophy (OPA1) as a probable risk gene for Tourette disorder through whole exome sequencing analyses of de novo mutations. The OPA1 protein localizes to the inner membrane of mitochondria in cells throughout the body, where it regulates mitochondrial morphology and function. The Tischfield lab has identified a TD patient with an OPA1 missense mutation, R904S, which we hypothesized would result in abnormal behavioral activity in mutant mice and/or affect the cellular function of mitochondria. We utilized several behavioral paradigms, including motion sequencing, the open field arena test, the marble burying task, and prepulse inhibition. These paradigms test various factors, such as behavioral dynamics, motor activity levels, and sensorimotor gating. To understand the cellular characterization, we observed whole brain expression of the protein, protein expression levels in different brain regions and mitochondria of cortical neurons. Preliminary results of mitochondria imaging show potential mitochondrial aggregates in heterozygous and homozygous mutant cortical neurons, which could indicate an increased preapoptotic state of mutant cells. Although the results of the remaining assays have been inconclusive, there are many variables that complicate the studies. For a better understanding of the variant, mitochondrial function should be tested in the future, such as oxidative phosphorylation activity, cytochrome c levels and reactive oxygen species levels. Cytochrome c levels and apoptosis assays especially should be conducted to better understand the nature of the observed mitochondrial aggregates. Identifying possible behavioral or cellular abnormalities of this variant is an important step in characterizing the mutation, determining its potential role in TD pathology, and developing potential clinical treatments for TD in the future